Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: Long-term results of a European organization for research and treatment of cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone

K Kurth*, U Tunn, R Ay, FH Schroder, M PavoneMacaluso, F Debruyne, F TenKate, M DePauw, R Sylvester, E Essed, RV Caubergh, JW Hoekstra, HJ deVoogt, DWW Newling, TM deReijke, HJA Mensink, JM Groen, G Jakse, HJ Leisinger, B RichardsRA Adib, M Robinson, L Denis, C Bouffioux, C Schulman, PJ Carpentier

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

60 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: Long-term results of a European organization for research and treatment of cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone'. Together they form a unique fingerprint.

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases